PTLF (Petlife Pharmaceuticals) EBITDA Margin %: 0.00% (As of Feb. 2018)


What is Petlife Pharmaceuticals EBITDA Margin %?

Petlife Pharmaceuticals PTLF EBITDA Margin % is 0.00% as of Feb. 2018.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Petlife Pharmaceuticals's EBITDA for the three months ended in Feb. 2018 was $-0.38 Mil. Petlife Pharmaceuticals's Revenue for the three months ended in Feb. 2018 was $0.00 Mil. Therefore, Petlife Pharmaceuticals's EBITDA margin for the quarter that ended in Feb. 2018 was 0.00%.

Petlife Pharmaceuticals  (OTCPK:PTLF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Petlife Pharmaceuticals EBITDA Margin % Related Terms

Petlife Pharmaceuticals EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals EBITDA Margin % Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PTLF vs PCYN, YBAO, BKIT: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Petlife Pharmaceuticals EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's EBITDA Margin % falls into.


Petlife Pharmaceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Petlife Pharmaceuticals's EBITDA Margin % for the fiscal year that ended in Aug. 2017 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2017 )/Revenue (A: Aug. 2017 )
=-22.873/0
= %

Petlife Pharmaceuticals's EBITDA Margin % for the quarter that ended in Feb. 2018 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2018 )/Revenue (Q: Feb. 2018 )
=-0.383/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Petlife Pharmaceuticals (PTLF) has a EBITDA Margin % of 0.00% as of Feb. 2018. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' EBITDA Margin % too high?
Petlife Pharmaceuticals' current EBITDA Margin % is 0.00%.
How does Petlife Pharmaceuticals' EBITDA Margin % compare to PCYN and YBAO?
Petlife Pharmaceuticals' EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Petlife Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Petlife Pharmaceuticals's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current EBITDA Margin % is 0.00% as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.